# A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension

> **NCT00788541** · PHASE2 · TERMINATED · sponsor: **Alcon Research** · enrollment: 197 (actual)

## Conditions studied

- Open-Angle Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Anecortave Acetate Sterile Suspension, 6 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 3.75 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 96 mg/mL
- **DRUG:** Anecortave Acetate Sterile Suspension, 60 mg/ML
- **OTHER:** Anecortave Acetate Vehicle

## Key facts

- **NCT ID:** NCT00788541
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-12
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 197 (ACTUAL)
- **Why stopped:** Project cancellation
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788541

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788541, "A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00788541. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*